Cat. No. 4125
Chemical Name: (1R,5S)-1,2,3,4,5,6-Hexahydro-9-(3-
Biological ActivityHigh affinity α4β2 partial agonist (Ki values are 0.91, 119 and 1100 nM for α4β2, α3β4 and α7 receptors respectively). Shows little activity at α3β4 and α7 receptors. Exhibits antidepressant-like effects in mouse models of antidepressant efficacy.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Papke et al (2011) Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists. J.Pharmacol.Exp.Ther. 337 1.
Papke et al (2010) Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J.Pharmacol.Exp.Ther. 333 501. PMID: 20100906.
Mineur et al (2009) Cytisine-based nicotinic partial agonists as novel antidepressant compounds. J.Pharmacol.Exp.Ther. 329 377. PMID: 19164465.
If you know of a relevant reference for 3-pyr-Cytisine please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses 3-pyr-Cytisine from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: 3-pyr-Cytisine, supplier, nicotinics, nachr, alpha4beta2, a4b2, α4β2, partial, agonists, Tocris Bioscience, Nicotinic (α4β2) Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs
July 8 - 12, 2017